Effectiveness of leukocytapheresis in suppressing the occurrence of surgical site infections following surgery for ulcerative colitis

Surgery Today

Volumn 38, Issue 7, 2008, Pages 609-617

  Itabashi, Michio ^a   Ikeuchi, Hiroki ^b   Araki, Toshimitsu ^c   Kono, Toru ^d   Nakamura, Toshio ^e   Takesue, Yoshio ^b   Kameoka, Shingo ^a   Kusunoki, Masato ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Granulocyte elastase; Leukocytapheresis; Neutrophil activity; Surgical site infection; Ulcerative colitis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; LEUKOCYTE ELASTASE; NAFAMSTAT MESILATE;

ABDOMINAL PAIN; ADULT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART RATE; HUMAN; HYPOTENSION; INFECTION RATE; LABORATORY TEST; LENGTH OF STAY; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PATIENT SAFETY; PATIENT SELECTION; STATISTICAL ANALYSIS; SURGICAL INFECTION; TREMOR; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; C-REACTIVE PROTEIN; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; HUMANS; JAPAN; LENGTH OF STAY; LEUKAPHERESIS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 47149087509     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3685-3     Document Type: Article

References (15)

1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for he Prevention of Surgical Site Infection. Infect Cont Hosp Epidemiol 1999;20:247-278.
2. Harihara Y, Konishi T. Surgeon's concern to surgical site infection: Effectiveness of SSI surveillance (in Japanese). Shokakigeka 2003;26:1193-1200.
3. Takesue Y, Kusunoki M, Kobayashi M, Kono T, Ebisawa Y, Watanebe T, et al. The prevalence of surgical site infection (SSI) by the introduction of the best practice in the perioperative management and operative manipulation; multi-center prospective study of 1,601 colorectal patients (in Japanese with English abstract). Nihon Geka Kansensho Gakkaizasshi (J Jpn Soc Surg Infect) 2006;3(4):471-476.
4. Itabashi M, Yoshimura Y, Suenaga K, Bamba Y, Takemoto K, Yamada A, et al. Surgical site infection after pouch operation for ulcerative colitis (in Japanese with English abstract). Nihon Geka Kansensho Gakkaizasshi (J Jpn Soc Surg Infect) 2006;3(2):161-165.
5. Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-321.
6. Kanai T, Hibi T, Watanabe M. The logic of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther 2006;6(5):453-466.
7. Imamura Y, Takesue Y, Sueda T. Changes in neutrophil functions in the early stage of systemic inflammation following surgical intervention (in Japanese with English abstract). Nihon Geka Kansensho Gakkaizasshi (J Jpn Soc Surg Infect) 2006;3(2):147-153.
8. Miki C, Yoshiyama S, Ohkita Y, Araki T, Uchida K, Kusunoki M. Strategy development for preventing postoperative infectious complication in patients with ulcerative colitis (in Japanese). Geka 2006;68(9):1012-1017.
9. Hirayama K, Koyama T. Adverse events of plasma exchange (in Japanese). Nihon Rinsho (Nippon rinsho) 2004;62suppl 5:319-322.
10. Yamamori Y, Saito Y, Hashimoto K, Sakura S, Uchida H, Kosaka Y. Evaluation of plasmapheresis for autoimmune neuromuscular diseases (in Japanese with English abstract). ICU to CCU (ICU & CCU) 1997;21(8):737-741.
11. Agishi T, Iwai T, Ishimaru S, Amano I, Azuma N. Cooperative multiinstitutional evaluation study of apheresis treatments for arteriosclerosis obliterans in the lower limbs without hyperlipidemia (in Japanese with English abstract). Nihon Apheresis Gakkaizasshi (Jpn J Apher) 2006;25(1):42-51.
12. Shimizu M, Tsuda H, Sanaka T, Ide K. Present status of therapeutic apheresis in Japan: survey report. Ther Apher 1998;2(3):172-181.
13. Klingel R, Fassbender C, Fassbender T, Göhlen B. Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine. Transfus Apheresis Sci 2003;29:71-84.
14. Miki C, Yoshiyama S, Okita Y, Araki T, Uchida K, Yanagi H, et al. Neutrophil priming as a surgery-related risk factor for postoperative infectious complications in patients with ulcerative colitis. Dig Surg 2006;23:179-185.
15. Ogawa R. Surgical injury and SIRS: Modification by anesthesia (in Japanese). Kyukyuigaku (Jpn J Acute Med) 1996;20:1099-1104.